Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "twoXAR" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about twoXAR for you to read. Along with our medical data and news we also list twoXAR Clinical Trials, which are updated daily. BioPortfolio also has a large database of twoXAR Companies for you to search.
Drug discovery startup twoXAR has raised $10 million in funding to support its efforts to build a pipeline of drug candidates found by its proprietary artificial intelligence technology. SoftBank Ventures led the Series A round of financing, and was joined by the Andreessen Horowitz Bio Fund and OS Fund. Palo Alto, CA-based twoXAR has developed […]
TwoXAR Inc. (using artificial intelligence in drug discovery) raised $10mm in a Series A financing led by SoftBank Ventures, ...
One-year-old twoXAR (artificial intelligence-based drug discovery) raised $3.4mm in seed financing led by Andreessen Horowitz...
Californian biopharma, TwoXAR, which is using a computational platform to identify drug candidates, de-risks opportunities through preclinical studies, and progresses...
The company, which is using an AI-based platform to comb through drug candidates in a much shorter time than traditional approaches require just raised $10 million.
The company, which is using an AI-based platform to comb through drug candidates in a much shorter time than traditional approaches require, just raised $10 million.
Andreessen Horowitz and OS Fund participate in Series A investment which will be used to build a portfolio of drug programs through biopharmaceutical partnerships twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, announced today that it has raised $10 million in Series A financing led by SoftBank Ventures, a SoftBank Group...
The market for a new FDA-approved indication in frontline classical Hodgkin lymphoma could be worth $650m to $750m, some analysts...
An international trial has demonstrated that HSCT was more effective than standard drugs for people with highly active relapsing-remitting multiple...
Shares of Indian hospital chain Fortis Healthcare have risen some 16% in the past month, fuelled by investor hopes of...
twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, announced that it has raised $10 million in Series A financing led by SoftBank Ventures, a SoftBank Group early stage venture capital arm. Joining SoftBank Ventures is the Andreessen Horowitz Bio Fund and OS Fund. The pr...
SummaryTwoxar Inc Twoxar is an artificial intelligencedriven drug discovery company which develops novel drug candidates. Its drug discovery technology platform evaluates public and proprietary datasets to identify high probability drugdisease matches based on orders of magnitude. The company builds its own pipeline of therapeutic candidates across diseases as well as collaborates with biotechnolo...